Oral care compositions and methods

Patent metadata

Field	Value
Publication number	US-2016331670-A1
Application number	US-201315106543-A
Country	US
Kind code	A1
Filing date	Dec 20, 2013
Priority date	Dec 20, 2013
Publication date	Nov 17, 2016
Grant date	—

Abstract

Provided is an oral care composition comprising a phosphate/acrylate co-polymer, a synthetic anionic linear polycarboxylate polymer, and an orally acceptable carrier; and methods of using the same.

First claim

1 . An oral care composition comprising a phosphate/acrylate co-polymer, a synthetic anionic linear polycarboxylate polymer, and an orally acceptable carrier.

2 . The composition of claim 1 , wherein the composition comprises 0.1 to 10 weight % phosphate/acrylate co-polymer.

3 . The composition of claim 1 , wherein the composition comprises 0.01 to 30 weight % synthetic anionic linear polycarboxylate.

4 . The composition of claim 1 , wherein the synthetic anionic linear polycarboxylate is a copolymer of maleic anhydride or acid and methyl vinyl ether.

5 . The composition of claim 1 , wherein the synthetic anionic linear polycarboxylate is 1:4 to 4:1 copolymer of methyl vinyl ether and maleic anhydride, wherein the anhydride is hydrolyzed after co-polymerization to provide the acid, having a weight average molecular weight (M.W.) of about 30,000 to about 1,000,000 Da.

6 . The composition of claim 1 which is a toothpaste comprising a silica abrasive.

7 . The composition of claim 1 , wherein the composition comprises an anti-bacterially effective amount of an antibacterial agent selected from the group consisting of triclosan, cetylpyridinium chloride (CPC), chlorhexidine (CHX), stannous salts, water soluble zinc salts, water insoluble zinc compounds, zinc oxide, zinc citrate, or a mixture thereof, optionally the antibacterial agent is triclosan.

8 . The composition of claim 1 , wherein the phosphate/acrylate co-polymer is a co-polymerized product of a mixture of acrylic acid, methacrylic acid, and 2-hydroxyethyl methacrylate phosphates of Formula 1:

wherein n is 0, 1 or 2.

9 . The composition of claim 8 , wherein the phosphate/acrylate co-polymer is a co-polymerized product of a mixture of acrylic acid, methacrylic acid, and 2-hydroxyethyl methacrylate phosphates of Formula 1 comprising acrylic acid in a molar percentage of 70-90%; methacrylic acid in a molar percentage of 5-20%, and hydroxyethyl methacrylate phosphates of Formula 1 in a molar percentage of 1-10%,

10 . The composition of claim 8 , wherein the phosphate/acrylate co-polymer is a co-polymerized product of a mixture of acrylic acid, methacrylic acid, and 2-hydroxyethyl methacrylate phosphates of Formula 1 comprising acrylic acid in a molar percentage of 80-90% or 85%; methacrylic acid in a molar percentage of 5-15% or 11%, and hydroxyethyl methacrylate phosphates of Formula 1 in a molar percentage of 2-6% or 4%.

11 . The composition of claim 1 , wherein the phosphate/acrylate copolymer is a random copolymer having a weight average molecular weight of 10,000 to 500,000, and the phosphate/acrylate copolymer is below it glass transition temperature.

12 . The composition of claim 11 , wherein the weight average molecular weight is 10,000 to 200,000 grams per mole, optionally, 10,000 to 40,000, 15,000 to 25,000, or 17,000 to 23,000 grams per mole.

13 . The composition of claim 1 which is a toothpaste or a mouthwash.

14 . A method for the treatment and/or inhibition of a chemical stain, plaque, acid erosion, and/or tartar on a dental surface, comprising contacting the dental surface with a composition of claim 1 .

15 . A use of any of the compositions of claim 1 for the treatment and/or inhibition of a chemical stain, plaque, acid erosion, and/or tartar on a dental surface.

16 . A method for the treatment and/or inhibition of gum disease comprising contacting the oral cavity with a composition of claim 1 .

17 . A use of any of the compositions of claim 1 for the treatment and/or inhibition of gum disease in an oral cavity.

18 . A method for the treatment and/or inhibition of halitosis comprising contacting the oral cavity with a composition of claim 1 .

19 . A use of any of the compositions according to claim 1 for the treatment and/or inhibition of halitosis in an oral cavity.

20 . A method for the inhibition of biofilm formation on a dental surface comprising contacting the oral cavity with a composition of claim 1 .

21 . A use of any of the compositions according to claim 1 for the inhibition of biofilm formation on a dental surface.

22 . A method for treating and/or inhibiting bacteria from sticking together and growing into bigger colonies in an oral cavity comprising contacting the oral cavity with a composition of claim 1 .

23 . A use of any of the compositions according to claim 1 for treating and/or inhibiting bacteria from sticking together and growing into bigger colonies in an oral cavity.

24 . A method of forming the composition of claim 1 as a mouth rinse that includes a zinc salt and a cationic antibacterial agent comprising:
(I) mixing water, surfactant, and a cationic antibacterial agent in a mixing tank to form a main mix;
(II) mixing 10-20 weight % of the total water, optionally 14-16 or 15 weight % of the total water, the phosphate/acrylate co-polymer, and a polyol to form a first premix,
(III) mixing 10-20 weight % of the total water, optionally 14-16 or 15 weight % of the total water first with the zinc and then adding the synthetic anionic linear polycarboxylate polymer (Gantrez) to form a second premix,
(IV) mixing the first premix into the main mix,
(V) after the first premix is added, mixing the second premix into the main mix,
(VI) optionally, mixing flavor and/or cooling agents with a glycol to form a third premix and adding the third premix to the main mix after the second premix is added.

25 . The method of claim 23 , wherein the cationic antibacterial active is cetylpyridinium chloride and the zinc salt is zinc chloride.

Assignees

• Colgate Palmolive Co

Inventors

• Prencipe Michael
• Jogun Suzanne
• Chen Xiang

Classifications

• A61P1/00

  Drugs for disorders of the alimentary tract or the digestive system · CPC title

• A61K2800/5424

  anionic · CPC title

• A61K8/27

  Zinc; Compounds thereof · CPC title

• A61K8/8152 Primary

  Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers · CPC title

• A61K8/4926

  having six membered rings · CPC title